Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Oncology·MeSH: Bronchiolitis Obliterans Syndrome
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Asciminib | Novartis AG (NVS) |
Phase 4(1)
| Drug | Company |
|---|---|
| asciminib | Novartis AG (NVS) |
Frequently asked questions
How many drugs are in development for Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase?
BioSniper tracks 2 drugs in development for Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase across 1 company.
How many clinical trials target Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase?
There are 1 clinical trial targeting Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase tracked by BioSniper.
Deep-dive into Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis